Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2020109442 - COMPOSITIONS ANTIVIRALES


Avertissement La version image (PDF) disponible dans PATENTSCOPE est la version officielle. Cette version HTML en ligne est fournie pour aider les utilisateurs. Malgré le grand soin apporté à la compilation pour assurer une représentation précise et exacte des données figurant sur le document/les images imprimés, des erreurs et/ou des omissions ne peuvent pas être exclues en raison des processus de transmission et de conversion de données et des limitations inhérentes aux processus de traduction (éventuellement) automatique utilisés. Les liens hypertexte suivis de ce symbole sont associés à des ressources externes qui ne sont pas contrôlées par l'OMPI. L'OMPI décline toute responsabilité concernant les points mentionnés ci-dessus.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/EP2019/082850 P1082WO
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
28 November 2019 29 November 2018
Applicant
DANIEL CALLADINE LIMITED
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No. ____________
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     A61K 31/522 (2006.01)i; A61K 9/00 (2006.01)i; A61K 47/06 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     A61K
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS, EMBASE, FSTA, WPI Data

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
X
WO 2013077881 A1 (3B PHARMACEUTICALS INC [US]; BROWN DARBY C [US]; BROWN KRISTEN A [US]) 30 May 2013 (2013-05-30)
1-24
paragraphs [0018] - [0019], [0036], [0069], [0070]
paragraphs [0068], [0067], [0072], [0093]
(2)
X
BE 1022817 B1 (STASISPORT PHARMA NV) 13 September 2016 (2016-09-13)
1-24
pages 2,4,5
pages 6,7
(3)
X
EP 0948332 A1 (RECORDATI CHEM PHARM [CH]) 13 October 1999 (1999-10-13)
1-24
paragraphs [0009], [0013] - [0025], [0048]
(4)
X
RU 2093140 C1 (TOVARISHCHESTVO S OGRANICHENNO [RU]) 20 October 1997 (1997-10-20)
1-24
page 4
(5)
X
RU 2282473 C2 (EHVALAR AOZT [RU]) 27 August 2006 (2006-08-27)
1-24
abstract
paragraphs [0016], [0027], [0031]
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"D"
document cited by the applicant in the international application
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
WO 2013077881 A1
30 May 2013
CA 2856696 A1
EP 2782585 A1
EP 3443964 A1
WO 2013077881 A1
30 May 2013
01 October 2014
20 February 2019
30 May 2013
BE 1022817 B1
13 September 2016
NONE
EP 0948332 A1
13 October 1999
AT 248597 T
AU 724741 B2
BR 9712610 A
CA 2270254 A1
CN 1235547 A
DE 69724647 D1
EP 0948332 A1
IT MI962258 A1
JP 2001503404 A
KR 20000052678 A
NZ 335685 A
WO 9818472 A1
15 September 2003
28 September 2000
21 December 1999
07 May 1998
17 November 1999
09 October 2003
13 October 1999
30 April 1998
13 March 2001
25 August 2000
27 March 2000
07 May 1998
RU 2093140 C1
20 October 1997
NONE
RU 2282473 C2
27 August 2006
NONE
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
06 January 2020
Date of mailing of the international search report:
14 January 2020
Authorized officer:
Lunter, Pim
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E